Skip to main content
Premium Trial:

Request an Annual Quote

Leiden Medical Center Installs Bruker Mass Spec Tools

NEW YORK (GenomeWeb News) — Bruker Daltonics said today that Leiden University Medical Center in the Netherlands has installed two of the company's FTMS systems for use in its proteomics research.

Leiden's researchers will use the company's 12 Tesla and 15 Tesla FTMS systems in protein characterization and analysis studies, Bruker said.

"In the last few years, the LUMC has invested significantly in creating a state-of-the-art proteomics infrastructure," and the new Bruker systems will enable more "in-depth characterization and quantitative analysis of the large number of sample generally encountered in clinical studies," Leiden researcher Andre Deelder said in a statement.

LUMC is conducting studies of proteomes and metabolomes of different body fluids from various patient cohorts in "bottom-up proteomics" studies.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.